Value of Stool-Based Colorectal Cancer Screening: Integrating Real-World Adherence, Detection, and Prevention in a Cohort-Based Modeling Analysis
A. Mark Fendrick, Derek W. Ebner, Michael Dore, Chris Estes, Gustavus Aranda, Mohammad Dehghani · 2025
Read Value of Stool-Based Colorectal Cancer Screening: Integrating Real-World Adherence, Detection, and Prevention in a Cohort-Based Modeling Analysis by A. Mark Fendrick, Derek W. Ebner, Michael Dore, Chris Estes, Gustavus Aranda, Mohammad Dehghani (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12786559.txt.
Description
Mark Fendrick and co-authors model the value of stool based screening for bowel cancer in the United States, in work from twenty twenty-five. Test cost alone misses the savings that come from finding cancer early or stopping it. The model folds in real world rates of test use and follow up.
One stool DNA test was compared with a simpler stool blood test for one round of screening. More people finished the DNA test, and it found far more cancers and risky growths at early stages. Its screening and follow up costs ran higher, but treatment costs ran lower. Total cost came out slightly lower for the DNA test. The authors say wider value counts beyond the test bill.
Catalog record
| CREATOR | A. Mark Fendrick, Derek W. Ebner, Michael Dore, Chris Estes, Gustavus Aranda, Mohammad Dehghani |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |